This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovations of Peter Bergsagel
Introduction
Peter Bergsagel is a notable inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His work focuses on developing methods and materials that enhance the understanding of drug responsiveness in cancer cells.
Latest Patents
Peter Bergsagel holds a patent for "Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs." This patent provides innovative methods and materials related to assessing how cancer cells, such as multiple myeloma cells, respond to these immunomodulatory drugs. The patent emphasizes the use of CRBN levels to determine susceptibility to lenalidomide and other related compounds, representing a promising advancement in cancer therapy.
Career Highlights
Bergsagel is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to contribute to groundbreaking research in oncology. His work has the potential to improve treatment outcomes for patients suffering from various forms of cancer.
Collaborations
Peter collaborates with esteemed colleagues, including Esteban Braggio and Alexander Keith Stewart. Their combined expertise enhances the research efforts at the Mayo Foundation, fostering an environment of innovation and discovery.
Conclusion
Peter Bergsagel's contributions to medical research and his innovative patent highlight his commitment to improving cancer treatment. His work exemplifies the importance of research in developing effective therapies for patients.